Cargando…

Population pharmacokinetics of nadroparin for thromboprophylaxis in COVID‐19 intensive care unit patients

AIMS: Nadroparin is administered to COVID‐19 intensive care unit (ICU) patients as thromboprophylaxis. Despite existing population pharmacokinetic (PK) models for nadroparin in literature, the population PK of nadroparin in COVID‐19 ICU patients is unknown. Moreover, optimal dosing regimens achievin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Romano, Lorenzo G. R., Hunfeld, Nicole G. M., Kruip, Marieke J. H. A., Endeman, Henrik, Preijers, Tim
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9878197/ https://www.ncbi.nlm.nih.gov/pubmed/36495312 http://dx.doi.org/10.1111/bcp.15634

Ejemplares similares

Optimising the Nadroparin Dose for Thromboprophylaxis During Hemodialysis by Developing a Population Pharmacodynamic Model Using Anti-Xa Levels
por: Jaspers, Tessa C. C., et al.
Publicado: (2022)

Population Pharmacokinetic Model and Pharmacokinetic Target Attainment of Micafungin in Intensive Care Unit Patients
por: Martial, Lisa C., et al.
Publicado: (2017)

Population Pharmacokinetics of Clotting Factor Concentrates and Desmopressin in Hemophilia
por: Preijers, Tim, et al.
Publicado: (2020)

Population Pharmacokinetics and Probability of Target Attainment Analysis of Nadroparin in Different Stages of COVID-19
por: Piwowarczyk, Paweł, et al.
Publicado: (2023)

Chemotherapy-associated thromboembolic risk in cancer outpatients and effect of nadroparin thromboprophylaxis: results of a retrospective analysis of the PROTECHT study
por: Barni, Sandro, et al.
Publicado: (2011)

Low and Highly Variable Exposure to Prophylactic LMWH Nadroparin in Critically Ill Patients: Back to the Drawing Board for Prophylactic Dosing?
por: Diepstraten, Jeroen, et al.
Publicado: (2022)

Bleeding complications of thromboprophylaxis with dabigatran, nadroparin or rivaroxaban for 6 weeks after total knee arthroplasty surgery: a randomised pilot study
por: van der Veen, Lucia, et al.
Publicado: (2021)

The right time to measure anti-Xa activity in critical illness: pharmacokinetics of therapeutic dose nadroparin
por: Sytema, Jelmer G., et al.
Publicado: (2023)

Pooled Population Pharmacokinetic Analysis for Exploring Ciprofloxacin Pharmacokinetic Variability in Intensive Care Patients
por: Guo, Tingjie, et al.
Publicado: (2022)

Thromboprophylaxis in Intensive Care Unit Patients: A Literature Review
por: Ejaz, Amna, et al.
Publicado: (2018)

Pharmacokinetics of Haloperidol in Critically Ill Patients: Is There an Association with Inflammation?
por: Li, Letao, et al.
Publicado: (2022)

Population pharmacokinetics and target attainment of ciprofloxacin in critically ill patients
por: Abdulla, Alan, et al.
Publicado: (2020)

Tinzaparin vs. Nadroparin Safety and Efficacy in Neurosurgery
por: Wilhelmy, Florian, et al.
Publicado: (2021)

Dose optimization of cefotaxime as pre‐emptive treatment in critically ill adult patients: A population pharmacokinetic study
por: Roelofsen, Eveline E., et al.
Publicado: (2022)

Nadroparine calcium or enoxaparine in acute coronary syndrome patients suffering renal insufficiency: The nadroparin versus enoxaparin (NaVe) study design
por: Gurfinkel, Enrique P, et al.
Publicado: (2004)

Effect of nadroparin on anti-Xa activity during nocturnal hemodialysis
por: Buitenwerf, Edward, et al.
Publicado: (2015)

Lupus anticoagulant associates with thrombosis in patients with COVID‐19 admitted to intensive care units: A retrospective cohort study
por: Noordermeer, Tessa, et al.
Publicado: (2022)

Using Residual Blood from the Arterial Blood Gas Test to Perform Therapeutic Drug Monitoring of Vancomycin: An Example of Good Clinical Practice Moving towards a Sustainable Intensive Care Unit
por: Smeets, T. J. L., et al.
Publicado: (2022)

Nadroparin calcium: Spontaneous retroperitoneal bleeding: 2 case reports
Publicado: (2022)

Aggressive Thromboprophylaxis Improves Clinical Process and Decreases the Need of Intensive Care Unit in Covid-19
por: Ugur, Murat, et al.
Publicado: (2021)

Ensuring timely thromboprophylaxis on a Medical Assessment Unit
por: Akinbobuyi, Oluwatosin, et al.
Publicado: (2016)

Chloride administration in the intensive care unit, an independent predictor of mortality
por: Smolders, S, et al.
Publicado: (2015)

Occurrence of Hospital-Associated Thrombosis in the Setting of Current Thromboprophylaxis Strategies: An Observational Cross-Sectional Study
por: Visser, Chantal, et al.
Publicado: (2023)

Optimising the dose of clonidine to achieve sedation in intensive care unit patients with population pharmacokinetics
por: Cloesmeijer, Michael E., et al.
Publicado: (2020)

Antitumor effects of nadroparin combined with radiotherapy in Lewis lung cancer models
por: Zhuang, Xibing, et al.
Publicado: (2018)

Effectiveness and Safety of Nadroparin Therapy in Preterm and Term Neonates with Venous Thromboembolism
por: Sol, Jeanine, et al.
Publicado: (2021)

Thromboprophylaxis in critical care
por: Helms, Julie, et al.
Publicado: (2022)

Health Care Costs of Target Attainment for Beta-Lactam Antibiotics in Critically Ill Patients: A Retrospective Analysis of the EXPAT Study
por: Ewoldt, Tim M. J., et al.
Publicado: (2022)

Population pharmacokinetic analysis of doripenem for Japanese patients in intensive care unit
por: Nonoshita, Ko, et al.
Publicado: (2020)

Rare complication of nadroparin injections: Skin necrosis and heparin‐induced thrombocytopenia syndrome
por: Malinauskiene, Laura, et al.
Publicado: (2022)

Sequential Therapy of Nadroparin and Rivaroxaban in the Initial Treatment of Patients With Acute Pulmonary Embolism
por: Xiong, Wei, et al.
Publicado: (2022)

Altered fibrin network structure and fibrinolysis in intensive care unit patients with COVID‐19, not entirely explaining the increased risk of thrombosis
por: de Vries, Judith J., et al.
Publicado: (2022)

Nadroparine-induced skin necrosis on a patient with essential thrombocythaemia: a case report
por: Pramateftakis, Manousos-Georgios, et al.
Publicado: (2009)

Fondaparınux Versus Nadroparın for Preventıon of Venous Thromboembolısm After Electıve Hıp and Knee Arthroplasty()
por: Argun, Mahmut, et al.
Publicado: (2013)

Preemptive dosage reduction of nadroparin in patients with renal failure: a retrospective case series
por: Russcher, Marije, et al.
Publicado: (2013)

Pharmacokinetics of dexmedetomidine infusions for patients in the intensive care unit
por: Venn, RM, et al.
Publicado: (2001)

Circular material flow in the intensive care unit—environmental effects and identification of hotspots
por: Hunfeld, Nicole, et al.
Publicado: (2022)

Modern thromboprophylaxis protocol based on guidelines applied in a respiratory intensive care unit: a single-center prospective cohort study
por: Tang, Xiao, et al.
Publicado: (2022)

Population pharmacokinetics of cefotaxime in intensive care patients
por: Swartling, Maria, et al.
Publicado: (2021)

Obstetric Thromboprophylaxis: The Swedish Guidelines
por: Lindqvist, Pelle G., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_0ah1tti0sop024467h49ug8gjc